Glenmark Pharmaceuticals has informed that at the annual general meeting (AGM) held on August 03, 2012, the shareholders have approved the dividend of Rs. 2 per share of Rs. 1 each (200%) on the equity share capital of the company for the financial year ended 2011-12.
The above information is a part of company's filings submitted to BSE.